3003: Medicaments with >=2 constituents mixed together, not for retail sale
COMESA
300310
Medicaments containing penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, not put up in measured doses/forms/packagings for RS
300320
Medicaments consisting of 2/more constituents, containing other antibiotics (excl. of 3003.10), not put up in measured doses/forms/packagings for RS
300331
Medicaments containing insulin, not put up in measured doses/forms/packagings for RS
300339
Medicaments containing hormones/other products of 29.37 but not containing antibiotics (excl. meds. containing insulin), not put up in measured doses/forms/packagings for RS
300340
Medicaments containing alkaloids/derivatives thereof but not containing hormones/other products of 29.37/antibiotics, not put up in measured doses/forms/packagings for RS
300390
Medicaments (excluding goods of heading 30.02, 30.05/30.06/of 3003.10-3003.40) consisting of two/more constituents which have been mixed together for therapeutic/prophylactic uses, not put up in measured doses/in forms/packings for retail sale
Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:
- The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
- The value added resulting from the process of production accounts for at least 25% of the ex-factory cost of the goods;
- Manufacture from materials classified in a heading other than that of the product
SADC
300310
Medicaments containing penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, not put up in measured doses/forms/packagings for RS
300320
Medicaments consisting of 2/more constituents, containing other antibiotics (excl. of 3003.10), not put up in measured doses/forms/packagings for RS
300331
Medicaments containing insulin, not put up in measured doses/forms/packagings for RS
300339
Medicaments containing hormones/other products of 29.37 but not containing antibiotics (excl. meds. containing insulin), not put up in measured doses/forms/packagings for RS
300340
Medicaments containing alkaloids/derivatives thereof but not containing hormones/other products of 29.37/antibiotics, not put up in measured doses/forms/packagings for RS
300390
Medicaments (excluding goods of heading 30.02, 30.05/30.06/of 3003.10-3003.40) consisting of two/more constituents which have been mixed together for therapeutic/prophylactic uses, not put up in measured doses/in forms/packings for retail sale
- Manufacture in which all the materials used are classified within a heading other than that of the product
EAC
300310
Medicaments containing penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, not put up in measured doses/forms/packagings for RS
300320
Medicaments consisting of 2/more constituents, containing other antibiotics (excl. of 3003.10), not put up in measured doses/forms/packagings for RS
300331
Medicaments containing insulin, not put up in measured doses/forms/packagings for RS
300339
Medicaments containing hormones/other products of 29.37 but not containing antibiotics (excl. meds. containing insulin), not put up in measured doses/forms/packagings for RS
300340
Medicaments containing alkaloids/derivatives thereof but not containing hormones/other products of 29.37/antibiotics, not put up in measured doses/forms/packagings for RS
300390
Medicaments (excluding goods of heading 30.02, 30.05/30.06/of 3003.10-3003.40) consisting of two/more constituents which have been mixed together for therapeutic/prophylactic uses, not put up in measured doses/in forms/packings for retail sale
Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:
- The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
- The value added resulting from the process of production accounts for at least 35% of the ex-factory cost of the goods;
- Manufacture from materials classified within a heading other than that of the product - Manufacture from any other heading is recognized as a substantial process.
EU GSP
Applicable HS codes (includes 2 exceptions)
300310
Medicaments containing penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, not put up in measured doses/forms/packagings for RS
300320
Medicaments consisting of 2/more constituents, containing other antibiotics (excl. of 3003.10), not put up in measured doses/forms/packagings for RS
300331
Medicaments containing insulin, not put up in measured doses/forms/packagings for RS
300339
Medicaments containing hormones/other products of 29.37 but not containing antibiotics (excl. meds. containing insulin), not put up in measured doses/forms/packagings for RS
300340
Medicaments containing alkaloids/derivatives thereof but not containing hormones/other products of 29.37/antibiotics, not put up in measured doses/forms/packagings for RS
300390
Medicaments (excluding goods of heading 30.02, 30.05/30.06/of 3003.10-3003.40) consisting of two/more constituents which have been mixed together for therapeutic/prophylactic uses, not put up in measured doses/in forms/packings for retail sale